Cargando…
Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy
BACKGROUND: Hypertrophic cardiomyopathy (HCM), described as the presence of hypertrophy of left ventricular, is the most prevalent heritable cardiovascular disease with predominantly an autosomal dominant type of inheritance. However, pathogenic alleles are not identified in at least 25% of patients...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606207/ https://www.ncbi.nlm.nih.gov/pubmed/34598319 http://dx.doi.org/10.1002/mgg3.1808 |
_version_ | 1784602296005427200 |
---|---|
author | Filatova, Elena V. Krylova, Natalia S. Vlasov, Ivan N. Maslova, Maria S. Poteshkina, Natalia G. Slominsky, Petr A. Shadrina, Maria I. |
author_facet | Filatova, Elena V. Krylova, Natalia S. Vlasov, Ivan N. Maslova, Maria S. Poteshkina, Natalia G. Slominsky, Petr A. Shadrina, Maria I. |
author_sort | Filatova, Elena V. |
collection | PubMed |
description | BACKGROUND: Hypertrophic cardiomyopathy (HCM), described as the presence of hypertrophy of left ventricular, is the most prevalent heritable cardiovascular disease with predominantly an autosomal dominant type of inheritance. However, pathogenic alleles are not identified in at least 25% of patients with HCM, and the spectrum of pathogenic variants that contribute to the development of HCM in Russia has not been fully described. Therefore, the goal of our study was to identify genetic variants associated with the etiopathogenesis of HCM in Russian patients. METHODS: The study cohort included 98 unrelated adult patients with HCM. We performed targeted exome sequencing, an analysis using various algorithms for prediction of the impact of variants on protein structure and the prediction of pathogenicity using ACMG Guidelines. RESULTS: The frequency of pathogenic and likely pathogenic variants in all HCM‐related genes was 8% in our patients. We also identified 20 variants of uncertain significance in all HCM‐related genes. CONCLUSIONS: The prevalence of individual pathogenic variants in HCM‐related genes in Russian population appears to be lower than in general European population, which could be explained by ethnic features of Russian population, age characteristics of our sample, or unidentified pathogenic variants in genes previously not linked with HCM. |
format | Online Article Text |
id | pubmed-8606207 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86062072021-11-29 Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy Filatova, Elena V. Krylova, Natalia S. Vlasov, Ivan N. Maslova, Maria S. Poteshkina, Natalia G. Slominsky, Petr A. Shadrina, Maria I. Mol Genet Genomic Med Original Articles BACKGROUND: Hypertrophic cardiomyopathy (HCM), described as the presence of hypertrophy of left ventricular, is the most prevalent heritable cardiovascular disease with predominantly an autosomal dominant type of inheritance. However, pathogenic alleles are not identified in at least 25% of patients with HCM, and the spectrum of pathogenic variants that contribute to the development of HCM in Russia has not been fully described. Therefore, the goal of our study was to identify genetic variants associated with the etiopathogenesis of HCM in Russian patients. METHODS: The study cohort included 98 unrelated adult patients with HCM. We performed targeted exome sequencing, an analysis using various algorithms for prediction of the impact of variants on protein structure and the prediction of pathogenicity using ACMG Guidelines. RESULTS: The frequency of pathogenic and likely pathogenic variants in all HCM‐related genes was 8% in our patients. We also identified 20 variants of uncertain significance in all HCM‐related genes. CONCLUSIONS: The prevalence of individual pathogenic variants in HCM‐related genes in Russian population appears to be lower than in general European population, which could be explained by ethnic features of Russian population, age characteristics of our sample, or unidentified pathogenic variants in genes previously not linked with HCM. John Wiley and Sons Inc. 2021-10-01 /pmc/articles/PMC8606207/ /pubmed/34598319 http://dx.doi.org/10.1002/mgg3.1808 Text en © 2021 Institute of Molecular Genetics of National Research Centre Kurchatov Institute. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Filatova, Elena V. Krylova, Natalia S. Vlasov, Ivan N. Maslova, Maria S. Poteshkina, Natalia G. Slominsky, Petr A. Shadrina, Maria I. Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy |
title | Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy |
title_full | Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy |
title_fullStr | Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy |
title_full_unstemmed | Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy |
title_short | Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy |
title_sort | targeted exome analysis of russian patients with hypertrophic cardiomyopathy |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606207/ https://www.ncbi.nlm.nih.gov/pubmed/34598319 http://dx.doi.org/10.1002/mgg3.1808 |
work_keys_str_mv | AT filatovaelenav targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy AT krylovanatalias targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy AT vlasovivann targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy AT maslovamarias targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy AT poteshkinanataliag targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy AT slominskypetra targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy AT shadrinamariai targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy |